We are live on ! Find out more
SAGE

Sage Therapeutics
SAGE

Delisted

SAGE was delisted on the 30th of July, 2025.

Back to rankings

204 hedge funds and large institutions have $1.1B invested in Sage Therapeutics in 2024 Q1 according to their latest regulatory filings, with 28 funds opening new positions, 70 increasing their positions, 61 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

57% more call options, than puts

Call options by funds: $5.76M | Put options by funds: $3.67M

17% more first-time investments, than exits

New positions opened: 28 | Existing positions closed: 24

15% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 61

2.38% more ownership

Funds ownership: 94.92% → 97.3% (+2.4%)

2% more funds holding

Funds holding: 200 → 204 (+4)

11% less capital invested

Capital invested by funds: $1.23B → $1.1B (-$138M)

Holders
204
Holders Change
+4
Holders Change %
+2%
% of All Funds
2.94%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
28
Increased
70
Reduced
61
Closed
24
Calls
$5.76M
Puts
$3.67M
Net Calls
+$2.09M
Net Calls Change
-$5.32M

Top Buyers

Rank Fund Capital Flow
1
BG
Bellevue Group
Switzerland
+$22M
2
Point72 Asset Management
Point72 Asset Management
Connecticut
+$14.8M
3
State Street
State Street
Massachusetts
+$13.3M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$9.96M
5
BBA
Baker Bros. Advisors
New York
+$9.39M

Top Sellers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
-$30.2M
2
CAC
Cowen and Company
New York
-$20.9M
3
JP Morgan Chase
JP Morgan Chase
New York
-$11.9M
4
Morgan Stanley
Morgan Stanley
New York
-$11.2M
5
Citadel Advisors
Citadel Advisors
Florida
-$6.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Capital Fund Management (CFM)
51
Capital Fund Management (CFM)
France
$2.5M +$1.39M +60,246 +83%
EIP
52
Easterly Investment Partners
Massachusetts
$2.05M -$301K -13,041 -11%
TD Asset Management
53
TD Asset Management
Ontario, Canada
$2.05M +$1.28M +55,612 +104%
Swiss National Bank
54
Swiss National Bank
Switzerland
$1.99M – – –
Qube Research & Technologies (QRT)
55
Qube Research & Technologies (QRT)
United Kingdom
$1.99M +$1.35M +58,694 +124%
TC
56
TwinBeech Capital
New York
$1.98M +$1.28M +55,468 +111%
WP
57
Woodline Partners
California
$1.96M +$2.42M +104,831 New
CS
58
Credit Suisse
Switzerland
$1.94M -$215K -9,312 -8%
Susquehanna International Group
59
Susquehanna International Group
Pennsylvania
$1.93M -$3.56M -154,527 -60%
ECM
60
ExodusPoint Capital Management
New York
$1.92M +$1.71M +74,341 +266%
CWM
61
CIBC World Markets
New York
$1.87M +$2.31M +100,000 New
Manulife (Manufacturers Life Insurance)
62
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$1.72M +$828K +35,877 +64%
Invesco
63
Invesco
Georgia
$1.6M +$496K +21,483 +34%
HSBC Holdings
64
HSBC Holdings
United Kingdom
$1.57M +$1.93M +83,577 New
Baillie Gifford & Co
65
Baillie Gifford & Co
United Kingdom
$1.51M -$91.1K -3,949 -5%
Barclays
66
Barclays
United Kingdom
$1.46M -$2.75M -119,146 -60%
RhumbLine Advisers
67
RhumbLine Advisers
Massachusetts
$1.45M +$40.3K +1,746 +2%
Mirae Asset Global Investments
68
Mirae Asset Global Investments
South Korea
$1.3M +$39.1K +1,693 +5%
HWAM
69
Hennion & Walsh Asset Management
New Jersey
$1.25M +$117K +5,068 +8%
Walleye Capital
70
Walleye Capital
New York
$1.24M -$79.4K -3,443 -5%
Aberdeen Group
71
Aberdeen Group
United Kingdom
$1.21M – – –
Canada Pension Plan Investment Board
72
Canada Pension Plan Investment Board
Ontario, Canada
$1.19M – – –
AllianceBernstein
73
AllianceBernstein
Tennessee
$1.15M – – –
PA
74
Profund Advisors
Maryland
$1.14M +$251K +10,870 +22%
UBS AM
75
UBS AM
Illinois
$1.13M +$122K +5,305 +10%
1 2
3
4 5

SAGE Hedge Fund Activity: Q1 2024 in Review

204 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Sage Therapeutics (SAGE) for Q1 2024, worth a combined $1.1B — down 11% from $1.23B a quarter earlier.

Buyers outnumbered sellers: 28 funds opened new SAGE positions and 24 closed out — a net gain of 4 holders — while 70 added to existing stakes and 61 trimmed.

The largest buyer was Bellevue Group, adding an estimated $22M. The largest seller was Wellington Management Group, cutting an estimated $30.2M.

  • 204 institutional investors held Sage Therapeutics (SAGE) as of Q1 2024, up from 200 in Q4 2023.
  • Funds reported $1.1B of Sage Therapeutics stock for Q1 2024, down 11% quarter-over-quarter.
  • 28 funds opened new Sage Therapeutics positions in Q1 2024 and 24 closed out, a net change of +4 holders.
  • The largest Sage Therapeutics buyer in Q1 2024 was Bellevue Group, an estimated $22M added.
  • The largest Sage Therapeutics seller in Q1 2024 was Wellington Management Group, an estimated $30.2M sold.

Based on aggregated 13F filings for Q1 2024.